Scientists have uncovered how a key type of immune cell adapts its behavior depending on the type of infection, paving the way for better vaccines and advancing research into immune-related diseases.

Bispecific antibodies can be manufactured in bulk, stored, and delivered like traditional antibody drugs. This means they ...

Their recent efforts have involved optimizing the therapy and expanding its uses to other cancers and diseases. The Inquirer ...

A tragic RSV vaccine trial in the 1960s set the field back for decades. Here’s how scientists finally made breakthroughs in ...

Mental health: Lupus causes issues with mental health and thinking, due to a cognitive impairment commonly known as “brain ...

Commit to Healthier Eating: Foods like fruits, vegetables, nuts, seeds, legumes and whole grains are recommended by experts ...

An engineering playbook for creating disease-resistant crops is finally here.

Results from OVATION 2 Study reinforce IMNN-001 efficacy benefits observed in the clinic and unique mechanism of action, producing key anti-cancer immune cytokines post-treatment ...

AK130 is the world’s first and only TIGIT/TGF-β bifunctional antibody fusion protein in registrational clinical development. The initiation of the AK130-202 study marks a significant milestone in ...

AI tool bridges the gap between doctor and patient and helps decode and simplify some of the post-therapy instructions for ...

While HPV is linked to cervical cancer, not every infection is dangerous, and with regular screening and vaccination, most ...

New research shows lymph nodes aren’t just cancer bystanders, they’re the command centers fueling immune attacks. Surgically ...